Bioventix Plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioventix Plc with three other
companies in this sector in the United Kingdom:
GW Pharmaceuticals PLC
sales of £9.45 million [US$12.18 million]
(£5.39 million [US$6.95 million]
of which 100%
was Pharmaceutical), and
C4X Discovery Holdings PLC
(£7.06 million [US$9.10 million]
During the year ended June of 2018, sales at
Bioventix Plc were £8.75 million (US$11.28 million).
increase of 20.8%
versus 2017, when the company's sales were £7.25 million.
This was the fifth consecutive year of sales increases at Bioventix Plc
(and since 2013, sales have increased a total of 223%).